Private company

Ambrx Biopharma Cayman, Inc.

Last updated Oct 16, 2026.

Overview

  • IndustryBiological Products, (No Diagnostic Substances)
  • HeadquartersE9
  • Incorporated inCayman Islands2
  • Business address10975 North Torrey Pines Road, La Jolla, Ca 920372
  • Filer category, Emerging growth company2

See how the biggest companies compare on our leaderboards

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Key numbers, fiscal 2022

-1032.2%Operating margin3
-1053.7%Net margin3
-0.7%Revenue growth, 20223
-66.2%Return on equity3
-$69.7MFree cash flow3

Where the money goes

Where each dollar of revenue went, fiscal 2022

  • Research and development95¢$53.3M
  • Interest2¢$968.0K
  • Income tax3¢$1.9M

Out of $7.4M in revenue.3 The company lost money this year.

Financial statements

Revenue43$7.4M in 2022−28% since 2019
0$5.0M$10.0M$15.0M2019: $10.3M$10.3M20192020: $13.7M$13.7M2020+33%2021: $7.5M$7.5M2021−45%2022: $7.4M$7.4M2022−1%
Operating income43-$76.4M in 2022+240% since 2019
-$80.0M-$60.0M-$40.0M-$20.0M02019: -$22.5M-$22.5M20192020: -$13.1M-$13.1M2020−42%2021: -$64.4M-$64.4M2021+391%2022: -$76.4M-$76.4M2022+19%
Net income43-$78.0M in 2022+289% since 2019
-$80.0M-$60.0M-$40.0M-$20.0M02019: -$20.1M-$20.1M20192020: -$16.5M-$16.5M2020−18%2021: -$68.1M-$68.1M2021+312%2022: -$78.0M-$78.0M2022+15%
Fiscal year20182019202020212022
Revenue$10.3M4$13.7M4$7.5M3$7.4M3
Research and development$26.4M4$20.4M4$54.3M3$53.3M3
Operating income-$22.5M4-$13.1M4-$64.4M3-$76.4M3
Interest$03$968.0K3
Income tax-$2.0K4$1.0K4$1.0K3$1.9M3
Net income-$20.1M4-$16.5M4-$68.1M3-$78.0M3
Earnings per share-$0.483-$0.293
Earnings per share (diluted)-$0.483-$0.293

Compare Ambrx Biopharma Cayman, Inc. with another company

Former names

  • Ambrx Biopharma Inc.Feb 3, 2021 to Oct 10, 20232

Recent filings

  1. Oct 12, 20238-K
  2. Oct 10, 20238-K
  3. Oct 6, 20238-K
  4. Sep 25, 20238-K
  5. Sep 19, 20234
  6. Sep 15, 20238-K
  7. Sep 6, 20238-K
  8. Sep 6, 20233
  9. Sep 6, 20234
  10. Aug 25, 20238-K
  11. Aug 9, 202310-Q
  12. Jul 7, 20234
  13. Jul 7, 20234
  14. Jul 7, 20234
  15. Jun 28, 20238-K

Every filing from the last three years, summarized. The full record is on SEC EDGAR.1

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6